Who owns BridgeBio Oncology Therapeutics Inc.?
Institutional ownership of BBOT from SEC Form 13F filings across 42 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
42
13F holders
$139.9M
value, 2026 filers
23.3%
of shares outstanding (18.7M sh)
12
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of BBOT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Alphabet Inc. | 2.8M | $21.5M | 0.0% | 3.5% | 0.0% |
| 2 | WELLINGTON MANAGEMENT GROUP LLP | 2.8M | $21.3M | 0.0% | 3.5% | -1.0% |
| 3 | CITADEL ADVISORS LLC | 2.6M | $19.9M | 0.0% | 3.3% | +3.5% |
| 4 | BlackRock, Inc. | 2.2M | $16.4M | 0.0% | 2.7% | +3.1% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $15.3M | 0.0% | 2.5% | +86.2% |
| 6 | Laurion Capital Management LP | 2.0M | $15.3M | 0.4% | 2.5% | +4.2% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 622,351 | $4.7M | 0.0% | 0.8% | +7.4% |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 400,000 | $3.0M | 0.0% | 0.5% | 0.0% |
| 9 | Catalio Capital Management, LPNEW | 318,407 | $2.4M | 0.5% | 0.4% | new |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | 300,000 | $2,286 | 0.0% | 0.4% | -31.5% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 291,522 | $2.2M | 0.0% | 0.4% | +14.6% |
| 12 | Sixth Street Partners Management Company, L.P.NEW | 286,518 | $2.2M | 0.4% | 0.4% | new |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 286,518 | $2.2M | 0.0% | 0.4% | -1.5% |
| 14 | FMR LLC | 240,587 | $1.8M | 0.0% | 0.3% | +0.1% |
| 15 | BNP PARIBAS FINANCIAL MARKETS | 191,152 | $1.5M | 0.0% | 0.2% | +110.5% |
| 16 | NORTHERN TRUST CORP | 186,482 | $1.4M | 0.0% | 0.2% | +82.4% |
| 17 | Sio Capital Management, LLC | 130,628 | $995,385 | 0.2% | 0.2% | 0.0% |
| 18 | UBS Group AG | 114,655 | $873,671 | 0.0% | 0.1% | +127.3% |
| 19 | MILLENNIUM MANAGEMENT LLC | 105,480 | $803,758 | 0.0% | 0.1% | -60.3% |
| 20 | GOLDMAN SACHS GROUP INC | 102,085 | $777,888 | 0.0% | 0.1% | -39.1% |
| 21 | MOORE CAPITAL MANAGEMENT, LP | 100,000 | $762,000 | 0.0% | 0.1% | 0.0% |
| 22 | Tidal Investments LLC | 93,339 | $711,243 | 0.0% | 0.1% | +13.6% |
| 23 | Tema ETFs LLC | 93,339 | $711,243 | 0.0% | 0.1% | +13.6% |
| 24 | Brevan Howard Capital Management LP | 88,895 | $690,714 | 0.0% | 0.1% | +523.9% |
| 25 | BANK OF AMERICA CORP /DE/NEW | 77,140 | $587,807 | 0.0% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.